 |
|
Researchers may have unlocked the mechanisms that silence the estrogen receptor gene alpha during breast cancer
August 20, 2007The mechanisms that silence the estrogen receptor gene alpha (ER-α) in certain breast cancer cell lines may be closer to being unlocked, according to a study by researchers at Temple University's Sbarro Institute for Cancer Research and Molecular Medicine.
The researchers reported their findings, "Epigenetic Modulation of Estrogen Receptor-α by pRb Family Proteins: A Novel Mechanism in Breast Cancer," in the Aug. 15 issue of the journal Cancer Research (http://cancerres.aacrjournals.org/
cgi/content/abstract/67/16/7731).
In a previous study, the researchers found that in estrogen receptor-positive and estrogen receptor-negative mammary cell lines of women who have been affected with breast cancer, the tumor-suppressing gene pRb2/p130 binds to a specific region of the estrogen receptor gene alpha and forms molecular complexes recruiting and/or interacting with several proteins. They discovered that in estrogen receptor-negative cells - which are able to silence the expression of the estrogen receptor - pRb2/p130 forms a specific molecular complex recruiting a different sequence of proteins than in the estrogen receptor-positive cells.
In the current study, lead by Antonio Giordano, M.D., Ph.D., director of the Sbarro Institute, the researchers showed that the presence of specific pRb2/p130 multimolecular complexes bound to the estrogen receptor gene strongly correlates with the methylation (chemical modification) of the gene.
"Our hypothesis is that the sequence of epigenetic events for establishing and maintaining the silenced state of the estrogen receptor gene alpha during the breast cancer progression is mediated by pRb2/p130 in association with specific proteins that modified the DNA structure through specific mechanisms," said Giordano, who discovered the Rb2 gene while working at Temple's Fels Cancer Institute in the early 1990s.
"In other words, the presence of a specific pRb2/p130 multimolecular complex may dictate a local change of the DNA structure of the estrogen receptor alpha gene and influence its susceptibility to chemical modification (DNA methylation), as well as to different epigenetic alterations leading to estrogen receptor alpha silencing," added Marcella Macaluso, research assistant professor at the Sbarro Institute and the study's lead author.
Giordano says this study provides a basis for understanding how the complex pattern of estrogen receptor gene alpha methylation and transcriptional silencing is generated, as well as for understanding the relationship between this pattern and its function during breast cancer progression.
By understanding this mechanism of how pRb2/p130 recruits molecules, he says, researchers will be able to design therapies and drugs that are very precise in the target they recognize.
"One gene on its own doesn't mean anything," he explains. "It's the dialogue among the genes that are writing the sentences, and this finding really writes a very important sentence in the book that we are authoring on uncovering the understanding of how a normal cell functions and why some therapies work or some therapies don't work. It also clearly shows that cancer is not the event of one gene, but an army of genes and it looks like pRb2/p130 is one of the generals."
Giordano and Macaluso were joined in this study by research fellow Micaela Montanari and doctoral students Paul Bart Noto and Valter Gregorio from the Sbarro Institute, and Professor Christian Bronner from the Centre National de la Recherche Scientifique/Université Louis Pasteur in France.
The study was coordinated by Giordano and carried out at Temple's Sbarro Institute and the Department of Human Pathology and Oncology at the University of Siena in Italy. It was funded by the National Institutes of Health, the U.S. Army Medical Research and Material Command and the Sbarro Health Research Organization.
Temple University
In the current study, lead by Antonio Giordano, M.D., Ph.D., director of the Sbarro Institute, the researchers showed that the presence of specific pRb2/p130 multimolecular complexes bound to the estrogen receptor gene strongly correlates with the methylation (chemical modification) of the gene.
"Our hypothesis is that the sequence of epigenetic events for establishing and maintaining the silenced state of the estrogen receptor gene alpha during the breast cancer progression is mediated by pRb2/p130 in association with specific proteins that modified the DNA structure through specific mechanisms," said Giordano, who discovered the Rb2 gene while working at Temple's Fels Cancer Institute in the early 1990s.
"In other words, the presence of a specific pRb2/p130 multimolecular complex may dictate a local change of the DNA structure of the estrogen receptor alpha gene and influence its susceptibility to chemical modification (DNA methylation), as well as to different epigenetic alterations leading to estrogen receptor alpha silencing," added Marcella Macaluso, research assistant professor at the Sbarro Institute and the study's lead author.
Giordano says this study provides a basis for understanding how the complex pattern of estrogen receptor gene alpha methylation and transcriptional silencing is generated, as well as for understanding the relationship between this pattern and its function during breast cancer progression.
By understanding this mechanism of how pRb2/p130 recruits molecules, he says, researchers will be able to design therapies and drugs that are very precise in the target they recognize.
"One gene on its own doesn't mean anything," he explains. "It's the dialogue among the genes that are writing the sentences, and this finding really writes a very important sentence in the book that we are authoring on uncovering the understanding of how a normal cell functions and why some therapies work or some therapies don't work. It also clearly shows that cancer is not the event of one gene, but an army of genes and it looks like pRb2/p130 is one of the generals."
Giordano and Macaluso were joined in this study by research fellow Micaela Montanari and doctoral students Paul Bart Noto and Valter Gregorio from the Sbarro Institute, and Professor Christian Bronner from the Centre National de la Recherche Scientifique/Université Louis Pasteur in France.
The study was coordinated by Giordano and carried out at Temple's Sbarro Institute and the Department of Human Pathology and Oncology at the University of Siena in Italy. It was funded by the National Institutes of Health, the U.S. Army Medical Research and Material Command and the Sbarro Health Research Organization.
Temple University
Estrogen News and Current Estrogen Events RSSSex differences seen in response to common antidepressant
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
Risk assessment plays key role in long-term treatment of breast cancer
Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence.
Estrogen relieves psychotic symptoms in women with schizophrenia
When combined with antipsychotic medications, the estrogen estradiol appears to be a useful treatment in women with schizophrenia, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Fish with temperature-dependent sex determination face global warming
In vertebrates with separate sexes, sex determination can be genotypic (GSD) or temperature-dependent (TSD). TSD is very common in reptiles, where the ambient temperature during sensitive periods of early development irreversibly determines whether an individual will be male or female.
Improved estrogen reception may sharpen fuzzy memory
Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs.
Treatment delays result in poor outcomes for men with breast cancer
Men who develop breast cancer are often not treated until the disease has spread to the point that treatment becomes difficult, new results show.
Researchers identify cancer preventive properties in common vitamin supplement
Early laboratory research has shown that resveratrol, a common dietary supplement, suppresses the abnormal cell formation that leads to most types of breast cancer, suggesting a potential role for the agent in breast cancer prevention.
Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis
Cancer patients with low socioeconomic status (SES) have more advanced cancers at diagnosis, receive less aggressive treatment, and have a higher risk of dying in the five years following cancer diagnosis, according to a new study.
Complex Changes in the Brain's Vascular System Occur after Menopause
Many women experience menopausal changes in their body including hot flashes, moodiness and fatigue, but the changes they don't notice can be more dangerous.
Estrogen therapy helps or hurts the brain depending on reproductive status
Estrogen therapy may limit stroke damage if started close to, but not long after reproductive cycles are over, according to a new animal study. The results were presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.
More Estrogen News Articles
 | From Belly Fat to Belly Flat: How Your Hormones Are Adding Inches to Your Waist and Subtracting Years from Your Life -- the Medically Proven Way to Reset Your Metabolism and Reshape Your Body by C.W. Randolph M.D., Genie James Discover the hidden culprit behind the 'middle-age spread'--and the simple plan that's helped hundreds of women over 30 break the fat cycle!It's an all-too-common problem once you hit thirty: Despite your best efforts, you just can't seem to lose the extra weight around your middle, and you look in the mirror wondering what month and year you lost your waistline. Medical research proves you're... |
 | Natural Hormone Balance for Women: Look Younger, Feel Stronger, and Live Life with Exuberance by Uzzi Reiss In Natural Hormone Balance for Women, Beverly Hills obstetrician-gynecologist Uzzi Reiss makes it clear that he believes in hormone replacement therapy for women, but not the "chemicalized hormonal substitutes" usually prescribed. "I emphasize natural hormones that are precise replicas of your own hormones," he writes, which can increase energy and memory, decrease symptoms of menopause and PMS,... |
 | The Anti-Estrogenic Diet: How Estrogenic Foods and Chemicals Are Making You Fat and Sick by Ori Hofmekler • Lower your risk of metabolic disorders, disease, and chronic weight gain• Protect yourself against the estrogenic substances in the environment, products, water, and foodLearn how certain foods and herbs can protect you!Estrogenic chemicals—known for causing the near extinction of various living species—are found in some of the most common foods we eat.In this... |
 | Dr. Susan Love's Menopause and Hormone Book: Making Informed Choices by Susan M. Love, Karen Lindsey In the first edition of this important bestselling book, praised by Newsday as “the bible for a whole generation of menopausal women,” renowned physician and pioneering women’s health advocate Dr. Susan Love warned about the potential dangers of the long-term prescription of hormone replacement therapy. Her insightful words of caution have been backed up by the stunning results... |
 | Better Bones, Better Body : Beyond Estrogen and Calcium by Susan E. Brown, Susan E. Brown PhD, Russell Jaffe MD Challenging traditional assumptions that estrogen and calcium deficiencies are the only causes of osteoporosis, this book explores the disorder from a wider perspective that includes lifestyle and exercise. This newly revised second edition features a personal osteoporosis risk assessment questionnaire and a step-by-step program for strengthening bones and improving overall health and... |
 | Natural Hormone Replacement For Women Over 45 by John Morgenthaler, Jonathan V. Wright A book showing that natural hormone replacement offers a safe and effective alternative for the treatment of... |
 | Screaming to Be Heard: Hormonal Connections Women Suspect and Doctors Ignore by Elizabeth Lee Vliet A physician describes how women should and can make their doctors take seriously their physical and emotional problems which are often... |
 | Menopause Without Medicine: The Trusted Women's Resource with the Latest Information on HRT, Breast Cancer, Heart Disease, and Natural Estrogens by Linda Ojeda Linda Ojeda has long maintained that menopause is a natural stage in a woman’s life, not a pathology that must be “medicalized.” In Menopause Without Medicine, she takes a sympathetic, science-based approach to this still poorly understood and often maltreated natural phenomenon. Now in its fifth edition, this definitive book includes a detailed response to recent findings from... |
 | The Estrogen Alternative: A Guide to Natural Hormonal Balance by Raquel Martin, Judi Gerstung With almost 100,000 copies sold in earlier editions, this revised edition provides the most up-to-date information on natural alternatives to synthetic hormone replacement therapyA must-read for any woman taking synthetic hormones for infertility, birthcontrol, PMS, or menopause• Includes the latest research on using natural progesterone to combat osteoporosis, endometriosis, heart... |
 | Living Somewhere Between Estrogen And Death by Barbara Johnson For women only, this is one of Barbara Johnson's most unique books. With her zany collection of observations about "life between the Blue Lagoon and Golden Pond," Barbara jumps right in, showing women how to survive growing older with courage and... |
| © 2008 BrightSurf.com |